Goodwin Procter is serving as legal counsel to Korro Bio, Latham & Watkins is serving as Frequency Therapeutics’ legal counsel, and Davis Polk is serving as...
You must be a Standard 1 Year member to access this content.
Fenwick & West LLP represented Chinook Therapeutics, Inc. on the transaction, while Hogan Lovells US LLP represented Novartis AG. Chinook Therapeutics, Inc. (Nasdaq: KDNY), a biopharmaceutical company, announced...
You must be a Standard 1 Year member to access this content.
Kirkland & Ellis and Simpson Thacher served as legal counsel to MultiPlan for the transaction, while Latham & Watkins served as legal advisory to Benefits Science....
You must be a Standard 1 Year member to access this content.
Latham & Watkins represented Immuneering in the offering, while Sidley Austin represented the underwriters involved. Immuneering Corporation (Nasdaq: IMRX) announced the pricing of its underwritten offering...
You must be a Standard 1 Year member to access this content.
Fenwick advised Shockwave Medical, Inc. on the deal. Shockwave Medical, Inc. (NASDAQ: SWAV), a medical device company focused on the development of Intravascular Lithotripsy (IVL) to...
You must be a Standard 1 Year member to access this content.
Fenwick represented SyntheX on the deal. SyntheX, a biotechnology company innovating next-generation functional drug discovery engines, announced its research collaboration and license agreement with Bristol Myers...
You must be a Standard 1 Year member to access this content.
Latham & Watkins represented Area 1 Security in the transaction. Cloudflare, Inc. (NYSE: NET), the security, performance, and reliability company helping to build a better Internet, has...
You must be a Standard 1 Year member to access this content.
